Oneness Biotech presented today at the J.P. Morgan Healthcare Conference, one of the world’s most influential healthcare investment events. President Dr. Shuling Cheng outlined the company’s global strategy and growth platform, emphasizing Oneness’ commitment to building a leading metabolic disease company. A key focus of the presentation was Bonvadis® (ON101) and its role in redefining wound care and limb preservation. Read More